The trial is going to use the Janssen Ebola Vaccine that was developed by Janssen Pharmaceutical company. Phase I and II human trials of the vaccine have already been carried out by the Oxford Vaccine Group in the United Kingdom
IP: 126.96.36.199. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.